Literature DB >> 22722020

Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.

Dina Bleumin1, Matan J Cohen, Olivier Moranne, Vincent L M Esnault, Shmuel Benenson, Ora Paltiel, Keren Tzukert, Irit Mor-Yosef Levi, Iddo Z Ben-Dov, Ronen Levi, Aharon Bloch, Yosef S Haviv.   

Abstract

BACKGROUND: Hemodialysis (HD) units have become a source of resistant bacteria. One of the most alarming developments is the emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP). Risk factors and outcomes of CRKP isolation in HD patients have not been previously studied.
METHODS: A nested case-control study was conducted in maintenance HD patients between January 1st 2006 and June 30th 2009. CRKP-positive patients were matched with randomly selected CRKP-negative HD patients. Demographics, clinical and laboratory data were collected for 24 months prior to the specimen collection. Multivariate analyses identified independent risk factors for CRKP. A prospective follow-up determined CRKP-associated outcome.
RESULTS: Demographics associated with CRKP acquisition in HD patients were age between 65 and 75 and having no living offspring. Clinical conditions associated with CRKP were previous hospitalization, temporary HD catheter and previous isolation of vancomycin-resistant enterococcus. CRKP-related outcome was poor: median survival of one month and a hazard ratio [95% CI] of 5.9 [3.2-11.0] for mortality.
CONCLUSIONS: Temporary HD catheters and previous treatment for VRE may predict subsequent CRKP isolation. A microbiological diagnosis of CRKP in HD patients is highly associated with imminent mortality. Meticulous measures to control the spread of CRKP bacteria among HD patients appear particularly warranted.
Copyright © 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722020     DOI: 10.1016/j.jinf.2012.06.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  11 in total

1.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes.

Authors:  Shanthi Mariappan; Uma Sekar; Arunagiri Kamalanathan
Journal:  Int J Appl Basic Med Res       Date:  2017 Jan-Mar

3.  Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy.

Authors:  Brandon Eilertson; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Yohei Doi; Keith S Kaye; Scott Evans; Vance G Fowler; Robert A Bonomo; Jack DeHovitz; Barry Kreiswirth; David van Duin
Journal:  Open Forum Infect Dis       Date:  2017-10-06       Impact factor: 3.835

4.  Coupling Machine Learning and High Throughput Multiplex Digital PCR Enables Accurate Detection of Carbapenem-Resistant Genes in Clinical Isolates.

Authors:  Luca Miglietta; Ahmad Moniri; Ivana Pennisi; Kenny Malpartida-Cardenas; Hala Abbas; Kerri Hill-Cawthorne; Frances Bolt; Elita Jauneikaite; Frances Davies; Alison Holmes; Pantelis Georgiou; Jesus Rodriguez-Manzano
Journal:  Front Mol Biosci       Date:  2021-11-23

5.  Comparison of Four Carbapenemase Detection Methods for blaKPC-2 Variants.

Authors:  Li Ding; Qingyu Shi; Renru Han; Dandan Yin; Shi Wu; Yang Yang; Yan Guo; Demei Zhu; Fupin Hu
Journal:  Microbiol Spectr       Date:  2021-12-22

6.  Clinical features and development of Sepsis in Klebsiella pneumoniae infected liver abscess patients: a retrospective analysis of 135 cases.

Authors:  Shixiao Li; Sufei Yu; Minfei Peng; Jiajia Qin; Chunyan Xu; Jiao Qian; Minmin He; Peng Zhou
Journal:  BMC Infect Dis       Date:  2021-06-23       Impact factor: 3.090

Review 7.  Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?

Authors:  Matthew J Cheesman; Aishwarya Ilanko; Baxter Blonk; Ian E Cock
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec

8.  A New Delhi metallo-β-lactamase (NDM)-positive isolate of Klebsiella pneumoniae causing catheter-related bloodstream infection in an ambulatory hemodialysis patient.

Authors:  Kevin H Toomer; Daniela de Lima Corvino; Katie A McCrink; Jose Armando Gonzales Zamora
Journal:  IDCases       Date:  2020-05-12

Review 9.  Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis.

Authors:  Amber Martin; Kyle Fahrbach; Qi Zhao; Thomas Lodise
Journal:  Open Forum Infect Dis       Date:  2018-06-28       Impact factor: 3.835

10.  Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.

Authors:  Yuanyuan Li; Jihong Li; Tong Hu; Jia Hu; Ning Song; Yu Zhang; Yuan Chen
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-01       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.